Statement Regarding Novel Coronavirus
Last updated August 12, 2020
The AACR is closely monitoring the continuing developments pertaining to the novel coronavirus. The safety and security of AACR conference attendees are our top priorities. After careful evaluation of currently available information, and a thorough consideration of all the factors essential to conduct a meeting, the AACR has determined that due to events beyond our control, it is in the best interest of all concerned to postpone the following conferences:
- Evolutionary Dynamics in Carcinogenesis and Response to Therapy (March 12-15, Denver, Colorado)
- Advances in Prostate Cancer Research (March 12-15, Denver, Colorado)
- CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference: Translating Science into Survival (September 14-17, 2020, New York, New York)
- Myeloma and Plasma Cell Dyscrasias (October 2-5, 2020, Boston, Massachusetts)
- Advances in Breast Cancer Research (October 9-12, 2020, San Diego, California)
- AACR-KCA Joint Conference on Precision Medicine in Solid Tumors (November 12-14, 2020, Seoul, South Korea)
The AACR and The Rivkin Center for Ovarian Cancer have also made the difficult decision to cancel the following meeting:
- 13th Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research (September 26-28, 2020, Seattle Washington)
Please Note: A Virtual Ovarian Cancer Research Seminar Series will now be held September 3, 10, 17, and 24
The information reviewed included the U.S. Federal government’s enforcement of travel prohibitions and restrictions on international travelers to enter the U.S., and the imposition of travel restrictions issued by cancer centers, academic institutions, and pharmaceutical companies. All of these factors materially affect the viability of the programs for these conferences, and the AACR has consequently made this difficult decision.
Please note that this decision applies to these conferences and does not impact other planned AACR events.
We recognize that the new data, exchange of information, and opportunities for collaboration offered by these conferences are highly valued by the cancer research community, and we are working to reschedule the conferences as soon as possible.
It is our current plan to continue with all other upcoming AACR meetings, as scheduled. We continue to track all travel restrictions issued by the U.S. Government, as well as information and guidance from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We will provide further updates as events warrant. Colleagues who have questions can contact the AACR by email at [email protected] or by phone at 215-440-9300 (international callers dial +1-215-440-9300).
January 11-12, 2021
January 13-14, 2021
February 3-5, 2021
The AACR organizes a variety of outstanding conferences, meetings, and workshops each year to advance our understanding of cancer and to facilitate the exchange of the most cutting-edge research in the field. The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research.
AACR Special Conferences present unique opportunities to interact with the world’s leading experts and discuss the latest findings in rapidly developing areas of cancer research. These popular conferences are relatively small (150-400 attendees) to allow ample time for discussion and networking.
The AACR’s educational workshops provide early-career investigators with opportunities to develop skills in clinical trial design, molecular biology, integrative molecular epidemiology, translational research, and related fields. Many programs supplement the educational aspects with mentoring, networking, and career development opportunities. Coupled with a broad array of Member Council (AMC) programs/initiatives, these programs prepare younger researchers for the next vital steps in their careers.
The AACR also holds a variety of meetings on a recurring basis, including such collaborative programs as the San Antonio Breast Cancer Symposium, the Molecular Targets and Cancer Therapeutics Conference, the International Cancer Immunotherapy Conference, and the Biennial Meeting on Advances in Malignant Lymphoma.
For more information, view the AACR’s current list of meetings, conferences, and educational workshops.